Aurora Biosciences (ABSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jay silberman who wrote ()	9/22/1997 10:07:00 PM
From: Philip H. Lee	of 359

Roy Whitfield, CEO of Incyte Pharmaceuticals, joins Aurora board, 9/15/97. biz.yahoo.com Aurora aurorabio.com is developing an integrated technology platform comprised of a portfolio of proprietary fluorescent assay technologies and an ultra-high throughput screening system designed to allow assay miniaturization and to overcome many of the limitations associated with the traditional drug discovery process. The Company believes that this platform will enable Aurora and its collaborators, which currently include Bristol-Myers Squibb, Eli Lilly and Company and Allelix Biopharmaceuticals, Inc., to take advantage of the opportunities created by recent advances in genomics and combinatorial chemistry that have generated many new therapeutic targets and an abundance of new small molecule compounds. Source: biz.yahoo.com Philip

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next